Navigation Links
Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
Date:5/11/2011

SAN DIEGO, May 11, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) and ViroPharma Incorporated (Nasdaq: VPHM), today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) in the development of a subcutaneous formulation of Cinryze (C1 esterase inhibitor [human]). Under terms of the agreement, Halozyme may receive up to $83 million, commencing with an upfront payment of $9 million and total potential future milestone payments of $74 million dependent upon the achievement of clinical and regulatory targets, plus a 10% royalty on future sales of the combination of Cinryze with rHuPH20. The license provides ViroPharma with exclusivity to C1 esterase inhibition and to the hereditary angioedema (HAE) indication, along with three additional orphan indications. ViroPharma will fund all development and commercialization expenses for the program. Additional terms of the transaction have not been disclosed.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

Cinryze has received FDA approval for intravenous administration for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema. A combination formulation of Cinryze with rHuPH20 for subcutaneous, or under the skin, administration is expected to enter clinical trials by the end of the year. The initial focus of the collaboration will be on the development of a novel subcutaneous formulation of Cinryze for routine prophylaxis against attacks of HAE.

"Halozyme's rHuPH20 enzyme may facilitate the subcutaneous administration and absorption of a broad range of pharmaceuticals and biologics, including plasma-derived proteins suc
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
2. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
3. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
4. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
5. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
6. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
7. Halozyme Therapeutics Realigns Management
8. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
9. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
10. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
11. Halozyme Therapeutics Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Research ... the "Physician Office Laboratory Markets, 3rd Edition" ... This report, Physician Office Laboratory Markets is Kalorama,s ... IVD industry. Physician office laboratories are diverse in ... perform reimbursable, in-office pregnancy and glucose tests. Some ...
(Date:9/23/2014)... , Sept. 23, 2014 This test can ... event. A "risk event" is defined by activities that can transfer ... tattoos, or use of any shared needles. , ... in oral fluid. This HIV test works by looking for ... Provides results in 20 minutes, enabling patients to learn their ...
(Date:9/23/2014)...  Hill-Rom (NYSE: HRC ) today announced ... Renton, WA ), the nation,s third largest not-for-profit ... relationship as Hill-Rom now becomes Providence Health,s sole-source provider ... and surface products. Providence Health is ... It operates 34 hospitals, 475 physician clinics, 22 long-term ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
... 16, 2011 InspireMD, Inc. (OTC BB: NSPR) ... mesh protective stent system, today announced that it has ... 30, 2011 with the U.S. Securities and Exchange Commission. The ... Year-to-Date Highlights Year-to-date shipment volumes ...
... 2011 Beacon Enterprise Solutions Group, Inc. (OTC ... leader in the design, implementation and management of ... today announces the award from teaming partner ICS ... leading provider of innovative technologies and solutions, to ...
Cached Medicine Technology:InspireMD Provides Mid-Year Strategic Update 2InspireMD Provides Mid-Year Strategic Update 3InspireMD Provides Mid-Year Strategic Update 4InspireMD Provides Mid-Year Strategic Update 5InspireMD Provides Mid-Year Strategic Update 6InspireMD Provides Mid-Year Strategic Update 7Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veteran's Administration 2Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veteran's Administration 3
(Date:9/23/2014)... Pallarito HealthDay Reporter TUESDAY, ... hospitals got paid for providing better care, not ... making informed health choices. A new report suggests ... The report, from the IMS Institute for Healthcare Informatics in ... expected to alter the delivery of health care and use ...
(Date:9/23/2014)... Washington, DC (PRWEB) September 23, 2014 ... affordable care? The National Quality Forum (NQF) ... sheet ( http://www.qualityforum.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=77687 ), and an infographic ( ... the rising cost of healthcare, how patients define ... for consumers to get the best possible healthcare ...
(Date:9/23/2014)... an exercise DVD that adds short breaks of physical ... found it had a high level of popularity with ... overly sedentary educational programs. , Called "Brain Breaks," the ... Program of the Linus Pauling Institute at Oregon State ... children in 5-7 minute segments of physical activity, demonstrated ...
(Date:9/23/2014)... 2014 Trevera provides multiple lines ... are Oracle Managed Services , Oracle Solutions ... versions of Oracle E-Business Databases and Applications, ... Trevera has announced a significant enhancement to its ... with their software technology management, project management, governance, ...
(Date:9/23/2014)... New York, New York (PRWEB) September 23, 2014 ... move forward in courts around the country, Bernstein Liebhard ... District Court, Middle District of Florida on September 19th, ... claims from a case filed in that jurisdiction on ... breast growth) and other complications due to his use ...
Breaking Medicine News(10 mins):Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... This dreadful HBV is small in size. The genome of ... fully double stranded, this genome carries about 3000 base pairs, ... the smallpox virus. These 3000 base pairs encode an envelope ... and a very special X protein, named such because its ...
... a curriculum-based bullying prevention program reduced incidents of bullying by ... group. , Jeffrey M. Jenson and William A. Dieterich of ... more than 1,100 students in 28 elementary schools in Denver ... prevention program called Youth Matters (YM). A second control ...
... in the journal Circulation, is the first to document a ... in mice, researchers say it is likely to give them ... , Dr. Brian Annex, professor of medicine and director ... from his clinical experience. Over and over, Id see ...
... adults have a higher prevalence of stroke than their European ... risk factors among Americans and barriers to care in the ... Stroke Associations International Stroke Conference 2008. , Compared to European ... a stroke and U.S. women had almost twice the odds ...
... Genetics and Public Policy Center will conduct a series of public ... views related to a proposed large cohort study on the role ... of a public consultation effort to inform the National Institutes of ... and how such a study might go forward. , One ...
... benefit for HIV, bone marrow transplantation patients , , FRIDAY, ... the thymus gland to produce new immune system T-cells ... HIV infection destroys T-cells, which leads to the collapse ... gland produces T-cells early in life but gradually loses ...
Cached Medicine News:Health News:Who found some new mechanisms of HBV virulence? 2Health News:University of Denver bullying victimization study 2Health News:Genetic mutation found in peripheral artery disease 2Health News:Stroke more prevalent in United States than in Europe 2Health News:Stroke more prevalent in United States than in Europe 3Health News:Genetic town halls to be held in 5 US cities 2Health News:Stimulating Thymus Reactivates T-Cell Production 2
Transparent film for easy visual monitoring of samples...
Adhesive tape sheets for sealing multiwell plates and blocks;...
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
... ThermalSeal is the only polypropylene based, pressure ... was developed with the assistance of a ... ThermalSeal prevents vapor loss and is ... at 75% humidity. It can be ...
Medicine Products: